Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.22
Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.